Preventing Pneumococcal Bacteremia in Patients at Risk
Authors:
- Barry M. FarrBFBarry M. Farr
- B. Lynn JohnstonBJB. Lynn Johnston
- David K. CobbDCDavid K. Cobb
- Michael J. FischMFMichael J. Fisch
- Teresa P. GermansonTGTeresa P. Germanson
- Karim A. AdalKAKarim A. Adal
- Anne M. AnglimAAAnne M. Anglim
- 27 November 1995
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 155 (21) , 2336-2340
Abstract
Research from JAMA Internal Medicine — Preventing Pneumococcal Bacteremia in Patients at Risk — Results of a Matched Case-Control StudyKeywords
This publication has 14 references indexed in Scilit:
- The pneumococcal vaccine after 15 years of useArchives of internal medicine (1960), 1994
- Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations1993
- Correction: Immunization Policies and Vaccine Coverage among Adults: The Risk for Missed OpportunitiesAnnals of Internal Medicine, 1988
- The Clinical Effectiveness of Pneumococcal Vaccine in the ElderlyAnnals of Internal Medicine, 1988
- Inefficacy of pneumococcal vaccine in a high-risk populationThe American Journal of Medicine, 1987
- Pneumococcal Vaccine Efficacy in Selected Populations in the United StatesAnnals of Internal Medicine, 1986
- A Controlled Evaluation of the Protective Efficacy of Pneumococcal Vaccine for Patients at High Risk of Serious Pneumococcal InfectionsAnnals of Internal Medicine, 1984
- Resolving the Pneumococcal Vaccine Controversy: Are There Alternatives to Randomized Clinical Trials?Clinical Infectious Diseases, 1984
- Some Observations on the Pneumococcus and on the Current Status of Pneumococcal Disease and Its PreventionClinical Infectious Diseases, 1981
- Prevention of Pneumococcal Infection by Immunization with Capsular Polysaccharides of Streptococcus pneumoniae: Current Status of Polyvalent VaccinesThe Journal of Infectious Diseases, 1977